Risk of virological failure after drug burden reduction in people with 4-class drug-resistant HIV on virological suppression: A retrospective cohort analysis of data from the PRESTIGIO Registry
Int J Antimicrob Agents. 2024 May 9;64(1):107195.
doi: 10.1016/j.ijantimicag.2024.107195.
Online ahead of print.
1 Vita-Salute San Raffaele University, Milan, Italy; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy. Electronic address: clemente.tommaso@hsr.it.
2 Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
3 National Institute for Infectious Diseases "L. Spallanzani" IRCCS, Rome, Italy.
4 III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy.
5 Infectious Diseases Unit, Verona, Italy.
6 Department of Medical Sciences, Unit of Infectious Diseases, University of Torino, Torino, Italy.
7 Department of Infectious Diseases, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy.
8 Department of Medical and Surgical Sciences, Unit of Infectious Diseases, S. Orsola Hospital, "Alma Mater Studiorum" University of Bologna, Bologna, Italy.
9 Department of Infectious Diseases, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
10 Infectious Diseases Unit, ASST Ovest Milanese, Legnano General Hospital, Legnano, Italy; DIBIC, University of Milan, Milan, Italy.
11 Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy.
12 Vita-Salute San Raffaele University, Milan, Italy; Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.